期刊文献+

洛铂诱导卵巢癌细胞SKOV3凋亡的研究 被引量:4

Apoptosis of human ovarian carcinoma cell SKOV3 induced by lobaplatin
原文传递
导出
摘要 目的探讨洛泊对体外培养的浆液性卵巢癌细胞SKOV3凋亡的诱导作用。方法体外培养卵巢癌细胞SKOV3,用MTT比色法检测洛铂对SKOV3细胞株的增殖抑制作用以及流式细胞仪检测洛铂对SKOV3细胞株的凋亡率。结果体外培养的卵巢癌SKOV3细胞经不同浓度的洛泊处理后细胞生长明显受到抑制,洛泊作用于卵巢癌SKOV3细胞可诱导细胞的凋亡。结论卵巢癌SKOV3细胞对洛泊敏感,洛泊对卵巢癌细胞的杀伤作用是通过诱导细胞凋亡途径实现的。 Objective To investigate the apoptosis of cultured human ovarian carcinoma cell SKOV3 induced by lobaplatin in vitro. Methods MTT assay was used to detect the effect of lobaplatin on proliferation, of human ovarian arcinoma cells and the apoptosis of SKOV3 cells were detectrd with by flow cytometry. Results Lobaplatin could inhibit the proliferation of SKOV3 cells significantly, After treatment with lobaplatin, SKOV3 cells showed some typical morphologic features of apoptosis. Conclursion Lobaplatin is capable of inhibiting the proliferation and inducing the apoptosis of SKOV3 cells.
出处 《中国热带医学》 CAS 2009年第7期1214-1215,共2页 China Tropical Medicine
关键词 洛泊 卵巢肿瘤 细胞凋亡 Lobaplatin Ovarian cells Apoptosis
  • 相关文献

参考文献5

  • 1Hickman J A.Apoptosis and chemotherapy resistance [J] . Eur J Cancer, 1996,32:921.
  • 2Aetema Laborries. Lobaplafin (D-19466)[J]. DrugsR and D,2003,4 (6):369-372.
  • 3Fiebig HH,Henb H,Vonpauel L,et al.Phase II clinical trial of Lobaplatin(D-19466) in pretreated patients with advanced smaii-cell lung cancer[J]. Onkologle, 1996,19:328-332.
  • 4姜文奇,林桐榆,徐瑞华,管忠震.乐铂单药治疗乳腺癌的Ⅱ期临床研究[J].实用癌症杂志,1998,13(4):294-295. 被引量:38
  • 5Lu paopei,Xu laping,Chen shanshan et al. Lobaplafin for treatment of chronic myeloid Leukemia (CML)-a pilot study [J] . Blood, 1997,90 (105):2766-3987.

共引文献37

同被引文献16

  • 1许卫华.慢性疼痛等级评价方法[J].中华口腔医学杂志,2005,40(5):427-427. 被引量:3
  • 2Kirpensteijn J,Teske E,Kik M,et al.Lobaplatfn as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phasell evaluation[J].Anticancer P.es, 2002,22(5): 2765-2770.
  • 3周建.农肿瘤药物治疗手册[M].南京:东南大学出版社,2005:125-131.
  • 4Gietema JA,Veldhufs H J, Guchelaar HJ,et al Phaseil and pharmacokinetic study of Iobaplatin in patients with relapsed ovarian cancer[J].Br J Cancer, 1995,71.1502-1507.
  • 5Kavanagh JJ,Creightoon L,Edwards CL,et al.Lobaplatin(D-19466)in platimum ovarian cancer[J].Gynecol 0ncol,1995,58:106-109.
  • 6Kirpensteijn J,Teske E,Kik M. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma a phase II evaluation[J].{H}Anticancer Research,2002,(5):2765-2770.
  • 7周建农.肿瘤药物治疗手册[M]{H}南京:东南大学出版社,2005125-131.
  • 8Li Y, Zhang ZN, Zhao HM, et al. Anti cancer drugs Matrine inhibits the invasive properties of human osteosarcoma ce]ls by downregulating the ERK NF kappa B pathway[J]. Anticancer Drugs 2014,25(9): 1035 1043.
  • 9Kan QC, Zhang S, Xu YM, et al. Matrine regulates glutamate related excitotoxlc factors in experimental autoimmune encephalomyelitis[J~. Neuroscience letters, 2014,560(2): 92-9?.
  • 10孙玉蓓,胡冰,王勇,何义富.重组人血管内皮抑素联合化疗治疗晚期大肠癌的临床观察[J].临床肿瘤学杂志,2009,14(9):837-840. 被引量:13

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部